Last updated on June 2019

Type 2 Diabetes (T2D) & Chronic Kidney Disease (CKD)


Brief description of study

A research study is evaluating the effects of Ozempic® (semaglutide), an FDA-approved antidiabetic medication, on renal impairment and cardiovascular conditions when added to current treatment for adults with type 2 diabetes.

 

Clinical Study Identifier: TX220960

Find a site near you

Start Over

PMG Research of Wilmington

1907 Tradd Court Wilmington, NC United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.